- Provides Broad Spectrum SPF 30 sunscreen with InVisibleZinc™ Technology
- MVE Technology: This patented delivery system continually releases moisturizing ingredients for all day hydration
- Ceramides: Essential for healthy skin, ceramides help restore and maintain the skin’s natural barrier
- Hyaluronic acid: This ingredient attracts hydration to the skin’s surface and helps the skin retain moisture
- Niacinamide: Helps the skin barrier and calms the skin
- Non-comedogenic, allergy tested, oil-free and fragrance-free
- Developed with dermatologists
- Recommended by The Skin Cancer Foundation
Volume: 89Ml
Only logged in customers who have purchased this product may leave a review.
Related Products
Axis-Y Dark Spot Correcting Glow Serum 50Ml
Original price was: ₨ 6,000.₨ 5,300Current price is: ₨ 5,300.
The Ordinary Ascorbyl Glucoside Solution 12%
Original price was: ₨ 4,400.₨ 2,995Current price is: ₨ 2,995.
The Ordinary 100% Organic Cold-Pressed Rose Hip Seed Oil
Original price was: ₨ 4,395.₨ 2,995Current price is: ₨ 2,995.
L’Oreal Paris Glycolic Bright Instant Glowing Face Serum – 15 ml
Original price was: ₨ 1,650.₨ 1,400Current price is: ₨ 1,400.
The Ordinary- Retinol 0.5% In Squalane: 30Ml
Original price was: ₨ 6,700.₨ 3,620Current price is: ₨ 3,620.
Garnier Bright Complete Vitamin C Serum – 15Ml
Original price was: ₨ 1,350.₨ 1,150Current price is: ₨ 1,150.
The Ordinary Multi-Peptide+HA Serum
Original price was: ₨ 4,990.₨ 2,990Current price is: ₨ 2,990.
Estelin Fullerene Serum Regenerating 40Ml
Original price was: ₨ 2,500.₨ 1,400Current price is: ₨ 1,400.
The Ordinary Multi Peptide Eye Serum
Original price was: ₨ 5,400.₨ 2,900Current price is: ₨ 2,900.
L’Oreal Paris Revitalift 1.5% Hyaluronic Acid Face Serum 15 Ml
Original price was: ₨ 2,000.₨ 1,700Current price is: ₨ 1,700.
The Ordinary Resveratrol 3% + Ferulic Acid 3%
Original price was: ₨ 4,990.₨ 3,290Current price is: ₨ 3,290.
The Ordinary- Caffeine Solution 5% + Egcg 30Ml
Original price was: ₨ 3,995.₨ 2,995Current price is: ₨ 2,995.
Reviews
There are no reviews yet.